Adoption of Falsified Medical Products in a Low-Income Country: Empirical Evidence for Suriname
Based on detailed shipping figures for Suriname’s main harbour in Paramaribo, we estimate the total shipments (in kilograms) of original and falsified medical products for 1996–2008 across five product categories. Using various time series techniques and diffusion models, we document that total cumu...
Main Authors: | Philip Hans Franses, Madesta Lede |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | Sustainability |
Subjects: | |
Online Access: | https://www.mdpi.com/2071-1050/9/10/1732 |
Similar Items
-
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01) -
Falsified Drugs in the Opinion of Patients Diagnosed with Cardiovascular Diseases—Nationwide and Cross-Sectional Study on the Example of EU-Member Country
by: Damian Świeczkowski, et al.
Published: (2021-04-01) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01) -
Falsified drugs as a challenge to public health - an attempt to define the concept and scale of the phenomenon in the world as well as legal and sociological approach
by: Damian Świeczkowski, et al.
Published: (2019-12-01) -
Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01)